z-logo
open-access-imgOpen Access
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
Author(s) -
Tzogani Kyriaki,
Hennik Paula Van,
Walsh Ita,
De Graeff Pieter,
Folin Annika,
Sjöberg Jan,
Salmonson Tomas,
Bergh Jonas,
Laane Edward,
Ludwig Heinz,
Gisselbrecht Christian,
Pignatti Francesco
Publication year - 2018
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2017-0301erratum
Subject(s) - medicine , panobinostat , refractory (planetary science) , oncology , multiple myeloma , intensive care medicine , histone deacetylase , histone , gene , physics , astrobiology , chemistry , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom